Skip to content
 

Health Care

Category profile

Products in this category relieve common health problems. Analgesics, Cold/Flu/Sore Throat and Gastro-Intestinals are generally over the counter medications for common ailments such as pain, fever, cold, flu, sore throat or heartburn.

Market position

Nurofen and Gaviscon are leading Analgesic and Gastro-Intestinal brands in Europe and Australia. Strepsils is No.1 in Sore Throat globally. Mucinex is the No. 1 cough brand in the US.

Click on the key brands in this category to find out more:

Strepsils | Mucinex | Nurofen | Gaviscon

Strepsils

StrepsilsStrepsils is the world's leading sore throat medicine. Trusted by consumers and pharmacists alike, this leading brand is now present in over 100 countries. From its inception as a sore throat gargle in 1950, the range has grown to a wide range of both lozenges and sprays, giving consumers the choice they want for treating their sore throats.

Principal Markets

Europe, Asia, Australasia, Africa and Middle East.

Back to top



Mucinex

MucinexMucinex is the US' leading cough and decongestion remedy. This brand came with the acquisition of the Adams business.

Principal Markets

Mucinex is the US’ leading cough and decongestion remedy.

Back to top



Nurofen

NurofenAvailable in 90 countries, Nurofen is the fastest growing analgesic brand globally and the leading analgesic brand in UK, Australia and New Zealand. Nurofen is available in a variety of formats including tablets, gel caps and liquids. Its range includes Nurofen for Children and heat patches for back pain and menstrual pain.

Principal Markets

Nurofen’s top 5 markets are UK, Australia, France, Russia and Belgium.

Back to top



Gaviscon

GavisconGaviscon is a well-established heartburn and indigestion remedy which provides long lasting relief though its unique raft-forming mode of action. It is prescribed by doctors and recommended by pharmacists and sufferers alike. Gaviscon Advance is stronger and offers longer lasting relief. Following its UK launch in 1997, it is now available in a number of countries globally.

Principal Markets

Africa & Middle East, Asia Pacific, Europe, Latin America, South Asia.

Back to top